Which incretin-based therapy for type 2 diabetes?

Lancet. 2014 Oct 11;384(9951):1325-7. doi: 10.1016/S0140-6736(14)61097-7. Epub 2014 Jul 10.
No abstract available

Publication types

  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glucagon-Like Peptide 1 / administration & dosage
  • Glucagon-Like Peptide 1 / analogs & derivatives*
  • Glucagon-Like Peptides / administration & dosage
  • Glucagon-Like Peptides / analogs & derivatives*
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Immunoglobulin Fc Fragments / administration & dosage*
  • Liraglutide
  • Male
  • Recombinant Fusion Proteins / administration & dosage*

Substances

  • Hypoglycemic Agents
  • Immunoglobulin Fc Fragments
  • Recombinant Fusion Proteins
  • Glucagon-Like Peptides
  • Liraglutide
  • Glucagon-Like Peptide 1
  • dulaglutide